Anne Wojcicki has been declared the winner of a bankruptcy auction for 23andMe, the genetics testing start-up she founded, prevailing over a rival bid from Regeneron Pharmaceuticals.
TTAM Research Institute, a non-profit public benefit company also founded by Wojcicki, won the auction with a $305 million bid for the 23andMe assets, which will not come with any company liabilities attached.
23andMe filed for bankruptcy in March after rejecting several go-private offers from Wojcicki in recent years. Regeneron was declared the winning bidder in May after the company accepted a $256 million bid in a previous auction.